ONCOCYTE CORP filed this S-3 on Oct 16, 2024
Click on link to view section or document
Back to Results
Entire Filing
Printer Friendly
NO.
DOCUMENT
1.
FORM S-3 (Entire Filing)
2.
FORM S-3 (Table of Contents)
a)
Subject to Completion, dated October 16, 2024
b)
TABLE OF CONTENTS
c)
ABOUT THIS PROSPECTUS
d)
THE OFFERING
e)
RISK FACTORS
f)
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
g)
USE OF PROCEEDS
h)
SELLING STOCKHOLDERS
BENEFICIAL OWNERS
i)
PLAN OF DISTRIBUTION
j)
LEGAL MATTERS
k)
EXPERTS
l)
WHERE YOU CAN FIND MORE INFORMATION
m)
PART II:
Item 14. Other Expenses of Issuance and Distribution
Item 15. Indemnification of Directors and Officers
Item 16. Exhibits
Item 17. Undertakings
n)
SIGNATURES
o)
POWER OF ATTORNEY
3.
EXHIBIT 5.1
4.
EXHIBIT 23.1
a)
Independent Registered Public Accounting Firm's Consent
5.
EXHIBIT 23.2
a)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
6.
EXHIBIT FILING FEES
